Literature DB >> 23932926

Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis.

Francesco Caso1, Ugo Fiocco1, Luisa Costa1, Paolo Sfriso1, Leonardo Punzi1, Andrea Doria2.   

Abstract

Entities:  

Keywords:  Anti-CD20 monoclonal antibody (rituximab); IgG4-RD; Scleritis

Mesh：

Substances：

Year:  2013        PMID： 23932926     DOI： 10.1016/j.jbspin.2013.07.011

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  9 in total

1.  Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.

Authors:  A Wu; N H Andrew; A Tsirbas; P Tan; A Gajdatsy; D Selva
Journal:  Eye (Lond)       Date:  2014-10-24       Impact factor: 3.775

Review 2.  From autoinflammation to autoimmunity: old and recent findings.

Authors:  Francesco Caso; Luisa Costa; Valeria Nucera; Giuseppe Barilaro; Ignazio Francesco Masala; Rossella Talotta; Paolo Caso; Raffaele Scarpa; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

3.  Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Luisa Costa; Vittoria Bascherini; Eugenia Latronico; Rossella Franceschini; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-09-16       Impact factor: 2.980

Review 4.  Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Authors:  Francesco Caso; Luisa Costa; Donato Rigante; Orso Maria Lucherini; Paolo Caso; Vittoria Bascherini; Bruno Frediani; Rolando Cimaz; Edoardo Marrani; Laura Nieves-Martín; Mariangela Atteno; Carmela G L Raffaele; Giusyda Tarantino; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2014-06-30       Impact factor: 4.711

Review 5.  IgG4-related disease: a systematic review of this unrecognized disease in pediatrics.

Authors:  Faiz Karim; Jan Loeffen; Wichor Bramer; Lauren Westenberg; Rob Verdijk; Martin van Hagen; Jan van Laar
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-25       Impact factor: 3.054

6.  Commentary: Rituximab in scleritis.

Authors:  Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

7.  Concurrent eosinophilia and IgG4-related disease in a child: A case report and review of the literature.

Authors:  Can Chen; Kuang Chen; Xilian Huang; Kaile Wang; Shenxian Qian
Journal:  Exp Ther Med       Date:  2018-01-12       Impact factor: 2.447

Review 8.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02

Review 9.  Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.

Authors:  Blaithin A McMahon; Tessa Novick; Paul J Scheel; Serena Bagnasco; Mohamed G Atta
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.